Immune medicines are promising therapies for debilitating disorders such as cancer, infectious disease, and inflammatory disease. By studying immune cell subsets, researchers gain insights into which patients will respond to various immunotherapies. To accelerate the timelines for finding cures, scientists use applications that decrease the space and time needed for assays that target single immune cells.
In this event brought to you by IsoPlexis, industry and academic leaders will describe how data from small yet powerful immune cell subsets shift conceptions about how humans mount effective immune responses, including which cells orchestrate a balanced attack. They will discuss technological advancements that enable all labs to detect powerful, highly active immune cell subsets by their functional proteome. Additionally, the speakers will highlight applications for harnessing these powerful cell subsets to advance cell and gene therapies.
Meet the speaker:
CEO and Co-Founder